• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. $11.04 Billion Next Generation Cancer Diagnostics Market 2017 By Technology, Application, Cancer Type, Function Companion Diagnostics - Forecasts to 2025 - Research and Markets

    $11.04 Billion Next Generation Cancer Diagnostics Market 2017 By Technology, Application, Cancer Type, Function Companion Diagnostics - Forecasts to 2025 - Research and Markets

  2. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  3. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

©2017 Morningstar Advisor. All right reserved.